Skip to Content
Merck
  • Comparison of two empiric antibiotic regimen in late onset neonatal sepsis--a randomized controlled trial.

Comparison of two empiric antibiotic regimen in late onset neonatal sepsis--a randomized controlled trial.

Journal of tropical pediatrics (2013-09-26)
Suresh Ramasamy, Niranjan Biswal, Adhisivam Bethou, Betsy Mathai
ABSTRACT

To compare the effectiveness of two antibiotic regimens among neonates with late onset sepsis (LOS). This randomized controlled trial conducted in a tertiary care teaching hospital, South India, included 90 babies with LOS. Detailed history, examination and appropriate investigations were done for all the babies. Cloxacillin + Amikacin were administered to 40 and Cefotaxime + Gentamicin to 50 babies. Outcomes including mortality, complications and treatment failure were evaluated. Chi-square test was used for categorical variables and Student's unpaired t-test for continuous variables. LOS had a male preponderance, and median time of onset was 13 days. Mortality was more among low birth weight babies irrespective of the antibiotics. Predominant bacteria isolated were coagulase-negative staphylococci (26.67%), Escherichia coli (13.33%) and Streptococcus pneumoniae (13.33%). Complications, mortality and cost were similar in both regimens. There was no significant difference between the two antibiotic regimens with regard to outcome of LOS.

MATERIALS
Product Number
Brand
Product Description

Cefotaxime acid, European Pharmacopoeia (EP) Reference Standard